171. The need for psycho-oncological support for melanoma patients: Central role of patients' self-evaluation. Issue 37 (September 2017) Authors: Mayer, Simone; Teufel, Martin; Schaeffeler, Norbert; Keim, Ulrike; Garbe, Claus; Eigentler, Thomas Kurt; Zipfel, Stephan; Forschner, Andrea Other Names: Sinnberg. Tobias section editor. Journal: Medicine Issue: Volume 96:Issue 37(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
172. The ROS‐induced cytotoxicity of ascorbate is attenuated by hypoxia and HIF‐1alpha in the NCI60 cancer cell lines. Issue 3 (14th December 2013) Authors: Sinnberg, Tobias; Noor, Seema; Venturelli, Sascha; Berger, Alexander; Schuler, Paul; Garbe, Claus; Busch, Christian Journal: Journal of cellular and molecular medicine Issue: Volume 18:Issue 3(2014) Page Start: 530 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
173. The safety and efficacy of cobimetinib for the treatment of BRAF V600E or V600K melanoma. Issue 7 (2nd July 2016) Authors: Amaral, Teresa; Nouri, Noura; Garbe, Claus Journal: Expert review of anticancer therapy Issue: Volume 16:Issue 7(2016) Page Start: 705 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
174. The sentinel lymph node spread determines quantitatively melanoma seeding to non-sentinel lymph nodes and survival. (March 2018) Authors: Ulmer, Anja; Dietz, Klaus; Werner-Klein, Melanie; Häfner, Hans-Martin; Schulz, Claudia; Renner, Philipp; Weber, Florian; Breuninger, Helmut; Röcken, Martin; Garbe, Claus; Fierlbeck, Gerhard; Klein, Christoph A. Journal: European journal of cancer Issue: Volume 91(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
175. Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials. (September 2017) Authors: Schadendorf, Dirk; Long, Georgina V.; Stroiakovski, Daniil; Karaszewska, Boguslawa; Hauschild, Axel; Levchenko, Evgeny; Chiarion-Sileni, Vanna; Schachter, Jacob; Garbe, Claus; Dutriaux, Caroline; Gogas, Helen; Mandalà, Mario; Haanen, John B.A.G.; Lebbé, Céleste; Mackiewicz, Andrzej; Rutkowski, Pi... Journal: European journal of cancer Issue: Volume 82(2017) Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
176. Toxic epidermal necrolysis in a melanoma patient under targeted therapy with encorafenib and binimetinib. (9th August 2020) Authors: Lang, Nina; Schinaia, Chiara Giulia; Wolfsperger, Frederik; Schaller, Martin; Forchhammer, Stephan; Garbe, Claus; Forschner, Andrea Journal: Journal der Deutschen Dermatologischen Gesellschaft Issue: Volume 18:Number 10(2020) Page Start: 1159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
177. Toxisch epidermale Nekrolyse bei einem Melanompatienten unter zielgerichteter Therapie mit Encorafenib und Binimetinib. (28th October 2020) Authors: Lang, Nina; Schinaia, Chiara Giulia; Wolfsperger, Frederik; Schaller, Martin; Forchhammer, Stephan; Garbe, Claus; Forschner, Andrea Journal: Journal der Deutschen Dermatologischen Gesellschaft Issue: Volume 18:Number 10(2020) Page Start: 1159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
178. Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies. Issue 1 (5th December 2019) Authors: Wagner, Nikolaus B.; Weide, Benjamin; Gries, Mirko; Reith, Maike; Tarnanidis, Kathrin; Schuermans, Valerie; Kemper, Charlotte; Kehrel, Coretta; Funder, Anne; Lichtenberger, Ramtin; Sucker, Antje; Herpel, Esther; Holland-Letz, Tim; Schadendorf, Dirk; Garbe, Claus; Umansky, Viktor; Utikal, Jochen; ... Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
179. Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma – results of a prospective biomarker study. Issue 1 (12th July 2019) Authors: Forschner, Andrea; Battke, Florian; Hadaschik, Dirk; Schulze, Martin; Weißgraeber, Stephanie; Han, Chung-Ting; Kopp, Maria; Frick, Maximilian; Klumpp, Bernhard; Tietze, Nicola; Amaral, Teresa; Martus, Peter; Sinnberg, Tobias; Eigentler, Thomas; Keim, Ulrike; Garbe, Claus; Döcker, Dennis; Biskup, ... Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
180. Update on tolerability and overall survival in COLUMBUS: landmark analysis of a randomised phase 3 trial of encorafenib plus binimetinib vs vemurafenib or encorafenib in patients with BRAF V600–mutant melanoma. (February 2020) Authors: Ascierto, Paolo A.; Dummer, Reinhard; Gogas, Helen J.; Flaherty, Keith T.; Arance, Ana; Mandala, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; de Groot, Jan Willem B.; Loquai, Carmen; Gollerkeri, Ashwin; Pickard, Michael D.; Robert, Caroline Journal: European journal of cancer Issue: Volume 126(2020) Page Start: 33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗